{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T19:43:56Z","timestamp":1793994236091,"version":"4.8.0"},"reference-count":192,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T00:00:00Z","timestamp":1720569600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005892","name":"China Academy of Chinese Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005892","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.ajps.2024.100943","type":"journal-article","created":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T16:46:26Z","timestamp":1720975586000},"page":"100943","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Design strategies, advances and future perspectives of colon-targeted delivery systems for the treatment of inflammatory bowel disease"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6459-8660","authenticated-orcid":false,"given":"Baoxin","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aihua","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajps.2024.100943_bib0001","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/ecco-jcc\/jjx101","article-title":"European Crohn's and Colitis Organisation topical review on treatment withdrawal ['exit strategies'] in inflammatory bowel disease","volume":"12","author":"Doherty","year":"2018","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.ajps.2024.100943_bib0002","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/imr.12192","article-title":"Macrophages in intestinal homeostasis and inflammation","volume":"260","author":"Bain","year":"2014","journal-title":"Immunol Rev"},{"key":"10.1016\/j.ajps.2024.100943_bib0003","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ajps.2024.100943_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105280","article-title":"Impact of gastrointestinal physiology on drug absorption in special populations\u2013an UNGAP review","volume":"147","author":"Stillhart","year":"2020","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.ajps.2024.100943_bib0005","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1053\/j.gastro.2011.02.045","article-title":"Conventional medical management of inflammatory bowel disease","volume":"140","author":"Burger","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajps.2024.100943_bib0006","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.gtc.2020.08.002","article-title":"Biologic Therapy for ulcerative colitis","volume":"49","author":"Bhattacharya","year":"2020","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.ajps.2024.100943_bib0007","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1056\/NEJMoa2212728","article-title":"Upadacitinib induction and maintenance therapy for Crohn's disease","volume":"388","author":"Loftus","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajps.2024.100943_bib0008","doi-asserted-by":"crossref","DOI":"10.1038\/s41577-024-01008-6","article-title":"Strategies for targeting cytokines in inflammatory bowel disease","author":"Neurath","year":"2024","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ajps.2024.100943_bib0009","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/s41579-019-0213-6","article-title":"Microbial genes and pathways in inflammatory bowel disease","volume":"17","author":"Schirmer","year":"2019","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ajps.2024.100943_bib0010","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.mayocp.2018.09.013","article-title":"Mechanisms of disease: inflammatory bowel diseases","volume":"94","author":"Ramos","year":"2019","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ajps.2024.100943_bib0011","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41572-020-0205-x","article-title":"Ulcerative colitis","volume":"6","author":"Kobayashi","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.ajps.2024.100943_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.114021","article-title":"Oral nanomedicine for modulating immunity, intestinal barrier functions, and gut microbiome","volume":"179","author":"Lee","year":"2021","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.ajps.2024.100943_bib0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cytogfr.2023.07.001","article-title":"Recent advances in the treatment of IBD: targets, mechanisms and related therapies","volume":"71\u201372","author":"Liu","year":"2023","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.ajps.2024.100943_bib0014","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1093\/ecco-jcc\/jjad053","article-title":"Results of the eighth scientific workshop of ECCO: prevention and treatment of postoperative recurrence in patients with crohn's disease undergoing an ileocolonic resection with ileocolonic anastomosis","volume":"17","author":"Ferrante","year":"2023","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.ajps.2024.100943_bib0015","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1080\/19490976.2017.1290757","article-title":"Intestinal microbiota, fecal microbiota transplantation, and inflammatory bowel disease","volume":"8","author":"Weingarden","year":"2017","journal-title":"Gut Microbes"},{"key":"10.1016\/j.ajps.2024.100943_bib0016","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1056\/NEJMoa2207940","article-title":"Mirikizumab as induction and maintenance therapy for ulcerative colitis","volume":"388","author":"D'Haens","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajps.2024.100943_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.127761","article-title":"Mucoadhesive and thermosensitive Bletilla striata polysaccharide\/chitosan hydrogel loaded nanoparticles for rectal drug delivery in ulcerative colitis","volume":"254","author":"Zhao","year":"2024","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.ajps.2024.100943_bib0018","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1517\/17425240903490401","article-title":"What should be considered on design of a colon-specific prodrug?","volume":"7","author":"Jung","year":"2010","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.ajps.2024.100943_bib0019","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/s41575-021-00539-w","article-title":"Foundations of gastrointestinal-based drug delivery and future developments","volume":"19","author":"Chu","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.ajps.2024.100943_bib0020","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.crohns.2014.05.006","article-title":"ECCO-EpiCom. Age-related differences in presentation and course of inflammatory bowel disease: an update on the population-based literature","volume":"8","author":"Duricova","year":"2014","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.ajps.2024.100943_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.114076","article-title":"Clinical translation of advanced colonic drug delivery technologies","volume":"181","author":"Awad","year":"2022","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.ajps.2024.100943_bib0022","doi-asserted-by":"crossref","first-page":"26298","DOI":"10.1021\/acsami.3c02128","article-title":"Colon-targeting angelica sinensis polysaccharide nanoparticles with dual responsiveness for alleviation of ulcerative colitis","volume":"15","author":"Xu","year":"2023","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.ajps.2024.100943_bib0023","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202170115","article-title":"Colon-targeted adhesive hydrogel microsphere for regulation of gut immunity and flora","volume":"8","author":"Liu","year":"2021","journal-title":"Adv Sci"},{"key":"10.1016\/j.ajps.2024.100943_bib0024","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1021\/acs.biomac.1c01233","article-title":"Preparation of oral core-shell zein nanoparticles to improve the bioavailability of glycyrrhizic acid for the treatment of ulcerative colitis","volume":"23","author":"Wu","year":"2022","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ajps.2024.100943_bib0025","doi-asserted-by":"crossref","first-page":"31085","DOI":"10.1021\/acsami.2c05642","article-title":"Yeast microcapsule mediated natural products delivery for treating ulcerative colitis through anti-inflammatory and regulation of macrophage polarization","volume":"14","author":"Feng","year":"2022","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.ajps.2024.100943_bib0026","doi-asserted-by":"crossref","first-page":"6358","DOI":"10.1021\/acsami.1c21700","article-title":"Biomimetic MOF nanoparticles delivery of c-dot nanozyme and CRISPR\/Cas9 system for site-specific treatment of ulcerative colitis","volume":"14","author":"Ma","year":"2022","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.ajps.2024.100943_bib0027","article-title":"Optimization study of combined enteric and time-dependent polymethacrylates as a coating for colon targeted delivery of 5-ASA pellets in rats with ulcerative colitis","volume":"168","year":"2022","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.ajps.2024.100943_bib0028","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.ijbiomac.2022.09.247","article-title":"ROS-responsive hyaluronic acid hydrogel for targeted delivery of probiotics to relieve colitis","volume":"222","author":"Huang","year":"2022","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.ajps.2024.100943_bib0029","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jconrel.2019.10.054","article-title":"A self-assembled, ROS-responsive Janus-prodrug for targeted therapy of inflammatory bowel disease","volume":"316","author":"Li","year":"2019","journal-title":"J Controll Release"},{"key":"10.1016\/j.ajps.2024.100943_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121364","article-title":"Inflammation-specific targeted carriers for local drug delivery to inflammatory bowel disease","volume":"281","author":"Kotla","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.ajps.2024.100943_bib0031","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1007\/s12274-017-1918-3","article-title":"Surface charge tunable nanoparticles for TNF-\u03b1 siRNA oral delivery for treating ulcerative colitis","volume":"11","author":"Iqbal","year":"2018","journal-title":"Nano Res"},{"key":"10.1016\/j.ajps.2024.100943_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2023.120887","article-title":"Oral delivery of porous starch-loaded bilayer microgels for controlled drug delivery and treatment of ulcerative colitis","volume":"314","author":"Wen","year":"2023","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.ajps.2024.100943_bib0033","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1039\/D2NR04968F","article-title":"Programmed pH-responsive core-shell nanoparticles for precisely targeted therapy of ulcerative colitis","volume":"15","author":"Zhang","year":"2023","journal-title":"Nanoscale"},{"key":"10.1016\/j.ajps.2024.100943_bib0034","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s11095-007-9358-5","article-title":"Gastric pH and gastric residence time in fasted and fed conscious cynomolgus monkeys using the Bravo pH system","volume":"25","author":"Chen","year":"2008","journal-title":"Pharm Res"},{"key":"10.1016\/j.ajps.2024.100943_bib0035","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1023\/A:1011984216775","article-title":"Dissolution testing as a prognostic tool for oral drug absorption: immediate release dosage forms","volume":"15","author":"Dressman","year":"1998","journal-title":"Pharm Res"},{"key":"10.1016\/j.ajps.2024.100943_bib0036","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1016\/S0142-9612(03)00213-8","article-title":"Pectin-based systems for colon-specific drug delivery via oral route","volume":"24","author":"Liu","year":"2003","journal-title":"Biomaterials"},{"key":"10.1016\/j.ajps.2024.100943_bib0037","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/1471-230X-11-145","article-title":"Gastric transit and small intestinal transit time and motility assessed by a magnet tracking system","volume":"11","author":"Wors\u00f8e","year":"2011","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.ajps.2024.100943_bib0038","doi-asserted-by":"crossref","first-page":"e13734","DOI":"10.1111\/nmo.13734","article-title":"Normative values for region-specific colonic and gastrointestinal transit times in 111 healthy volunteers using the 3D-Transit electromagnet tracking system: influence of age, gender, and body mass index","volume":"32","author":"Nandhra","year":"2020","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.ajps.2024.100943_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2019.115613","article-title":"Chitosan-modified lipid nanodrug delivery system for the targeted and responsive treatment of ulcerative colitis","volume":"230","author":"Chen","year":"2020","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.ajps.2024.100943_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2008.07.009","article-title":"The gastrointestinal microbiota as a site for the biotransformation of drugs","volume":"363","author":"Sousa","year":"2008","journal-title":"Int J Pharm"},{"key":"10.1016\/j.ajps.2024.100943_bib0041","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ijbiomac.2021.06.088","article-title":"Pectin in biomedical and drug delivery applications: a review","volume":"185","author":"Li","year":"2021","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.ajps.2024.100943_bib0042","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ijbiomac.2022.12.271","article-title":"Guar gum-based nanoformulations: implications for improving drug delivery","volume":"229","author":"Garg","year":"2023","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.ajps.2024.100943_bib0043","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.carbpol.2016.04.077","article-title":"Novel cross linked guar gum-g-poly(acrylate) porous superabsorbent hydrogels: characterization and swelling behaviour in different environments","volume":"149","author":"Chandrika","year":"2016","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.ajps.2024.100943_bib0044","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ijbiomac.2011.04.022","article-title":"Prospective of guar gum and its derivatives as controlled drug delivery systems","volume":"49","author":"Prabaharan","year":"2011","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.ajps.2024.100943_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.reactfunctpolym.2023.105634","article-title":"Chitosan: a review on properties, biological activities and recent progress in biomedical applications","volume":"191","author":"Harugade","year":"2023","journal-title":"React Funct Polym"},{"key":"10.1016\/j.ajps.2024.100943_bib0046","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.carbpol.2018.06.107","article-title":"Colon-targeted dexamethasone microcrystals with pH-sensitive chitosan\/alginate\/Eudragit S multilayers for the treatment of inflammatory bowel disease","volume":"198","author":"Oshi","year":"2018","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.ajps.2024.100943_bib0047","first-page":"78","article-title":"Hyaluronic acid in inflammation and tissue regeneration","volume":"28","author":"Litwiniuk","year":"2016","journal-title":"Wounds"},{"key":"10.1016\/j.ajps.2024.100943_bib0048","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2022.120153","article-title":"Absorption, metabolism, and functions of hyaluronic acid and its therapeutic prospects in combination with microorganisms: a review","volume":"299","author":"Zheng","year":"2023","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.ajps.2024.100943_bib0049","doi-asserted-by":"crossref","first-page":"5009","DOI":"10.1002\/jsfa.8955","article-title":"Starch digestibility: past, present, and future","volume":"100","author":"Bello-Perez","year":"2020","journal-title":"J Sci Food Agric"},{"key":"10.1016\/j.ajps.2024.100943_bib0050","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.ejpb.2012.04.017","article-title":"Hydroxyethyl starch-based polymers for the controlled release of biomacromolecules from hydrogel microspheres","volume":"81","author":"W\u00f6hl-Bruhn","year":"2012","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.ajps.2024.100943_bib0051","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2022.119624","article-title":"Recent advances in the preparation, characterization, and food application of starch-based hydrogels","volume":"291","author":"Cui","year":"2022","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.ajps.2024.100943_bib0052","doi-asserted-by":"crossref","first-page":"951","DOI":"10.3390\/gels9120951","article-title":"Starch-based hydrogels as a drug delivery system in biomedical applications","volume":"9","author":"Lee","year":"2023","journal-title":"Gels"},{"key":"10.1016\/j.ajps.2024.100943_bib0053","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.carbpol.2017.02.080","article-title":"Alginate-polyvinyl alcohol based interpenetrating polymer network for prolonged drug therapy, Optimization and in-vitro characterization","volume":"166","author":"Anwar","year":"2017","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.ajps.2024.100943_bib0054","doi-asserted-by":"crossref","first-page":"5738","DOI":"10.1021\/jf2005468","article-title":"An oral colon-targeting controlled release system based on resistant starch acetate: synthetization, characterization, and preparation of film-coating pellets","volume":"59","author":"Pu","year":"2011","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.ajps.2024.100943_bib0055","article-title":"Dual pH and microbial-sensitive galactosylated polymeric nanocargoes for multi-level targeting to combat ulcerative colitis","volume":"18","author":"Zeeshan","year":"2023","journal-title":"Asian J Pharm Sci"},{"key":"10.1016\/j.ajps.2024.100943_bib0056","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1016\/j.apsb.2020.11.003","article-title":"Receptor-mediated targeted drug delivery systems for treatment of inflammatory bowel disease: opportunities and emerging strategies","volume":"11","author":"Liu","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.ajps.2024.100943_bib0057","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2023.120551","article-title":"Mannose-methyl-\u03b2-cyclodextrin suppresses tumor growth by targeting both colon cancer cells and tumor-associated macrophages","volume":"305","author":"Ohno","year":"2023","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.ajps.2024.100943_bib0058","first-page":"4223","article-title":"Biodistribution and endocytosis of ICAM-1-targeting antibodies versus nanocarriers in the gastrointestinal tract in mice","volume":"7","author":"Mane","year":"2012","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.ajps.2024.100943_bib0059","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.1039\/C9BM00925F","article-title":"A PepT1 mediated medicinal nano-system for targeted delivery of cyclosporine A to alleviate acute severe ulcerative colitis","volume":"7","author":"Wu","year":"2019","journal-title":"Biomater Sci"},{"key":"10.1016\/j.ajps.2024.100943_bib0060","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jconrel.2014.04.046","article-title":"Fab'-bearing siRNA TNF\u03b1-loaded nanoparticles targeted to colonic macrophages offer an effective therapy for experimental colitis","volume":"186","author":"Laroui","year":"2014","journal-title":"J Control Release"},{"key":"10.1016\/j.ajps.2024.100943_bib0061","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1016\/j.apsb.2020.07.019","article-title":"Lactoferrin-mediated macrophage targeting delivery and patchouli alcohol-based therapeutic strategy for inflammatory bowel diseases","volume":"10","author":"Zhao","year":"2020","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.ajps.2024.100943_bib0062","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1021\/ar7000815","article-title":"Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases","volume":"41","author":"Low","year":"2008","journal-title":"Acc Chem Res"},{"key":"10.1016\/j.ajps.2024.100943_bib0063","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1039\/c3tb21564d","article-title":"Glycoprotein CD98 as a receptor for colitis-targeted delivery of nanoparticle","volume":"2","author":"Xiao","year":"2014","journal-title":"J Mater Chem B"},{"key":"10.1016\/j.ajps.2024.100943_bib0064","doi-asserted-by":"crossref","first-page":"33948","DOI":"10.1021\/acsami.1c09804","article-title":"Oral core-shell nanoparticles embedded in hydrogel microspheres for the efficient site-specific delivery of magnolol and enhanced antiulcerative colitis therapy","volume":"13","author":"Wang","year":"2021","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.ajps.2024.100943_bib0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2023.120884","article-title":"Hyaluronic acid modified oral drug delivery system with mucoadhesiveness and macrophage-targeting for colitis treatment","volume":"313","author":"Zhang","year":"2023","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.ajps.2024.100943_bib0066","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/s41575-022-00675-x","article-title":"The role of goblet cells and mucus in intestinal homeostasis","volume":"19","author":"Gustafsson","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.ajps.2024.100943_bib0067","doi-asserted-by":"crossref","first-page":"8875","DOI":"10.2147\/IJN.S210315","article-title":"Nanoparticle-mediated drug delivery systems for the treatment of ibd: current perspectives","volume":"14","author":"Yang","year":"2019","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.ajps.2024.100943_bib0068","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijpharm.2012.07.017","article-title":"Drug delivery to inflamed colon by nanoparticles: comparison of different strategies","volume":"440","author":"Coco","year":"2013","journal-title":"Int J Pharm"},{"key":"10.1016\/j.ajps.2024.100943_bib0069","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202004692","article-title":"An orally administered ceo2@montmorillonite nanozyme targets inflammation for inflammatory bowel disease therapy","volume":"30","author":"Zhao","year":"2020","journal-title":"Adv Funct Mater"},{"key":"10.1016\/j.ajps.2024.100943_bib0070","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/7918261","article-title":"Oxidative stress and effect of treatment on the oxidation product decomposition processes in ibd","volume":"2018","author":"Dudzi\u0144ska","year":"2018","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.ajps.2024.100943_bib0071","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/j.ymthe.2023.02.017","article-title":"Reactive oxygen species-responsive nanocarrier ameliorates murine colitis by intervening colonic innate and adaptive immune responses","volume":"31","author":"Yan","year":"2023","journal-title":"Mol Ther"},{"key":"10.1016\/j.ajps.2024.100943_bib0072","doi-asserted-by":"crossref","first-page":"eabj2372","DOI":"10.1126\/sciadv.abj2372","article-title":"A nanoparticulate dual scavenger for targeted therapy of inflammatory bowel disease","volume":"8","author":"Shi","year":"2022","journal-title":"Sci Adv"},{"key":"10.1016\/j.ajps.2024.100943_bib0073","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1039\/C5SC03583J","article-title":"A self-reporting AIE probe with a built-in singlet oxygen sensor for targeted photodynamic ablation of cancer cells","volume":"7","author":"Yuan","year":"2016","journal-title":"Chem Sci"},{"key":"10.1016\/j.ajps.2024.100943_bib0074","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.actbio.2016.12.004","article-title":"Near-infrared light triggered drug delivery system for higher efficacy of combined chemo-photothermal treatment","volume":"51","author":"Chen","year":"2017","journal-title":"Acta Biomater"},{"key":"10.1016\/j.ajps.2024.100943_bib0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119379","article-title":"A dual pH and microbiota-triggered coating (Phloral\u2122) for fail-safe colonic drug release","volume":"583","author":"Varum","year":"2020","journal-title":"Int J Pharm"},{"key":"10.1016\/j.ajps.2024.100943_bib0076","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119372","article-title":"OPTICORE\u2122, an innovative and accurate colonic targeting technology","volume":"583","author":"Varum","year":"2020","journal-title":"Int J Pharm"},{"key":"10.1016\/j.ajps.2024.100943_bib0077","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/s41573-024-00914-7","article-title":"The landscape of small-molecule prodrugs","volume":"23","author":"Fralish","year":"2024","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.ajps.2024.100943_bib0078","article-title":"Glucocorticoids-based prodrug design: current strategies and research progress","volume":"19","author":"Liu","year":"2024","journal-title":"Asian J Pharm Sci"},{"key":"10.1016\/j.ajps.2024.100943_bib0079","doi-asserted-by":"crossref","first-page":"6601","DOI":"10.1021\/acsnano.2c12233","article-title":"Lipid prodrug nanoassemblies via dynamic covalent boronates","volume":"17","author":"Ding","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.ajps.2024.100943_bib0080","doi-asserted-by":"crossref","first-page":"12358","DOI":"10.1021\/acsnano.3c01599","article-title":"Remote Activation of Enzyme Nanohybrids for Cancer Prodrug Therapy Controlled by Magnetic Heating","volume":"17","author":"Torres-Herrero","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.ajps.2024.100943_bib0081","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1517\/17425250903228842","article-title":"Balsalazide in treating colonic diseases","volume":"5","author":"Tursi","year":"2009","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.ajps.2024.100943_bib0082","doi-asserted-by":"crossref","first-page":"9039","DOI":"10.1021\/acs.analchem.0c01220","article-title":"Precisely traceable drug delivery of azoreductase-responsive prodrug for colon targeting via multimodal imaging","volume":"92","author":"Zhao","year":"2020","journal-title":"Anal Chem"},{"key":"10.1016\/j.ajps.2024.100943_bib0083","doi-asserted-by":"crossref","first-page":"G155","DOI":"10.1152\/ajpgi.00311.2015","article-title":"JAK inhibition using tofacitinib for inflammatory bowel disease treatment: a hub for multiple inflammatory cytokines","volume":"310","author":"Danese","year":"2016","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.ajps.2024.100943_bib0084","doi-asserted-by":"crossref","first-page":"4926","DOI":"10.1021\/acs.jmedchem.1c02166","article-title":"Discovery of a colon-targeted azo prodrug of tofacitinib through the establishment of colon-specific delivery systems constructed by 5-asa-paba-mac and 5-asa-paba-diamine for the treatment of ulcerative colitis","volume":"65","author":"Zhao","year":"2022","journal-title":"J Med Chem"},{"key":"10.1016\/j.ajps.2024.100943_bib0085","doi-asserted-by":"crossref","first-page":"26932","DOI":"10.1021\/jacs.3c10015","article-title":"Triggerable prodrug nanocoating enables on-demand activation of microbial and small-molecular therapeutics for combination treatment","volume":"145","author":"Kuang","year":"2023","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.ajps.2024.100943_bib0086","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.addr.2020.07.002","article-title":"Liposomes: advancements and innovation in the manufacturing process","volume":"154-155","author":"Shah","year":"2020","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.ajps.2024.100943_bib0087","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1080\/10717544.2016.1177136","article-title":"Pharmaceutical liposomal drug delivery: a review of new delivery systems and a look at the regulatory landscape","volume":"23","author":"Zylberberg","year":"2016","journal-title":"Drug Deliv"},{"key":"10.1016\/j.ajps.2024.100943_bib0088","doi-asserted-by":"crossref","first-page":"3","DOI":"10.15171\/apb.2017.002","article-title":"Application of various types of liposomes in drug delivery systems","volume":"7","author":"Alavi","year":"2017","journal-title":"Adv Pharm Bull"},{"key":"10.1016\/j.ajps.2024.100943_bib0089","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113851","article-title":"Liposome composition in drug delivery design, synthesis, characterization, and clinical application","volume":"176","author":"Large","year":"2021","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.ajps.2024.100943_bib0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2023.146796","article-title":"Macrophage-biomimetic liposomes delivery of carbon dots nanozymes ameliorate ulcerative colitis by modulating inflammation pathways and remodeling the redox microenvironment","volume":"477","author":"Ma","year":"2023","journal-title":"Chem Eng J"},{"key":"10.1016\/j.ajps.2024.100943_bib0091","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11095-022-03460-2","article-title":"Structure and function of cationic and ionizable lipids for nucleic acid delivery","volume":"40","author":"Sun","year":"2023","journal-title":"Pharm Res"},{"key":"10.1016\/j.ajps.2024.100943_bib0092","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jconrel.2022.11.022","article-title":"Optimization of storage conditions for lipid nanoparticle-formulated self-replicating RNA vaccines","volume":"353","author":"Kim","year":"2023","journal-title":"J Controll Release"},{"key":"10.1016\/j.ajps.2024.100943_bib0093","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202203022","article-title":"The effect of cryoprotectants and storage conditions on the transfection efficiency, stability, and safety of lipid-based nanoparticles for mrna and dna delivery","volume":"12","author":"Kafetzis","year":"2023","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.ajps.2024.100943_bib0094","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1021\/acs.accounts.1c00544","article-title":"Chemistry of lipid nanoparticles for rna delivery","volume":"55","author":"Eygeris","year":"2022","journal-title":"Acc Chem Res"},{"key":"10.1016\/j.ajps.2024.100943_bib0095","doi-asserted-by":"crossref","first-page":"16982","DOI":"10.1021\/acsnano.1c04996","article-title":"Lipid nanoparticles-from liposomes to mrna vaccine delivery, a landscape of research diversity and advancement","volume":"15","author":"Tenchov","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.ajps.2024.100943_bib0096","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.2217\/nnm-2017-0196","article-title":"Oral administration of ginger-derived nanolipids loaded with siRNA as a novel approach for efficient siRNA drug delivery to treat ulcerative colitis","volume":"12","author":"Zhang","year":"2017","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ajps.2024.100943_bib0097","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121707","article-title":"Oral delivery of IL-22 mRNA-loaded lipid nanoparticles targeting the injured intestinal mucosa: a novel therapeutic solution to treat ulcerative colitis","volume":"288","author":"Sung","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.ajps.2024.100943_bib0098","doi-asserted-by":"crossref","first-page":"eaba2987","DOI":"10.1126\/sciadv.aba2987","article-title":"Chimeric apoptotic bodies functionalized with natural membrane and modular delivery system for inflammation modulation","volume":"6","author":"Dou","year":"2020","journal-title":"Sci Adv"},{"key":"10.1016\/j.ajps.2024.100943_bib0099","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1039\/D1CS01022K","article-title":"Silicon-containing nanomedicine and biomaterials: materials chemistry, multi-dimensional design, and biomedical application","volume":"53","author":"Chen","year":"2024","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.ajps.2024.100943_bib0100","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/adma.201104763","article-title":"Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery","volume":"24","author":"Tang","year":"2012","journal-title":"Adv Mater"},{"key":"10.1016\/j.ajps.2024.100943_bib0101","doi-asserted-by":"crossref","first-page":"3862","DOI":"10.1039\/c3cs35405a","article-title":"Synthesis of mesoporous silica nanoparticles","volume":"42","author":"Wu","year":"2013","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.ajps.2024.100943_bib0102","doi-asserted-by":"crossref","first-page":"6480","DOI":"10.1039\/C5TB00634A","article-title":"A soft-hard template approach towards hollow mesoporous silica nanoparticles with rough surfaces for controlled drug delivery and protein adsorption","volume":"3","author":"Zhang","year":"2015","journal-title":"J Mater Chem B"},{"key":"10.1016\/j.ajps.2024.100943_bib0103","doi-asserted-by":"crossref","first-page":"24404","DOI":"10.1021\/acsnano.3c11089","article-title":"Orally administrated inflamed colon-targeted nanotherapeutics for inflammatory bowel disease treatment by oxidative stress level modulation in colitis","volume":"17","author":"Min","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.ajps.2024.100943_bib0104","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/17425247.2019.1551874","article-title":"Yeast-inspired drug delivery: biotechnology meets bioengineering and synthetic biology","volume":"16","author":"Sabu","year":"2019","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.ajps.2024.100943_bib0105","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.3390\/molecules26113123","article-title":"Yeast cells in microencapsulation. General features and controlling factors of the encapsulation process","volume":"26","author":"Coradello","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ajps.2024.100943_bib0106","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201606134","article-title":"Metal-organic framework (MOF)-based drug\/cargo delivery and cancer therapy","volume":"29","author":"Wu","year":"2017","journal-title":"Adv Mater"},{"key":"10.1016\/j.ajps.2024.100943_bib0107","doi-asserted-by":"crossref","first-page":"7004","DOI":"10.1021\/acsami.1c01089","article-title":"Metal-organic frameworks for drug delivery: a design perspective","volume":"13","author":"Lawson","year":"2021","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.ajps.2024.100943_bib0108","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1021\/acs.accounts.9b00039","article-title":"Metal-organic framework-templated biomaterials: recent progress in synthesis, functionalization, and applications","volume":"52","author":"Begum","year":"2019","journal-title":"Acc Chem Res"},{"key":"10.1016\/j.ajps.2024.100943_bib0109","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jconrel.2017.03.026","article-title":"Biomimetics in drug delivery systems: a critical review","volume":"253","author":"Sheikhpour","year":"2017","journal-title":"J Control Release"},{"key":"10.1016\/j.ajps.2024.100943_bib0110","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/s41551-021-00792-z","article-title":"Amelioration of systemic inflammation via the display of two different decoy protein receptors on extracellular vesicles","volume":"5","author":"Gupta","year":"2021","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.ajps.2024.100943_bib0111","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202304023","article-title":"Orally-delivered, cytokine-engineered extracellular vesicles for targeted treatment of inflammatory bowel disease","volume":"19","author":"Liu","year":"2023","journal-title":"Small"},{"key":"10.1016\/j.ajps.2024.100943_bib0112","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1038\/s41467-022-31171-0","article-title":"Programmable probiotics modulate inflammation and gut microbiota for inflammatory bowel disease treatment after effective oral delivery","volume":"13","author":"Zhou","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajps.2024.100943_bib0113","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122107","article-title":"Engineering fucoxanthin-loaded probiotics' membrane vesicles for the dietary intervention of colitis","volume":"297","author":"Liang","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.ajps.2024.100943_bib0114","doi-asserted-by":"crossref","first-page":"10106","DOI":"10.7150\/thno.48448","article-title":"Amelioration of ulcerative colitis via inflammatory regulation by macrophage-biomimetic nanomedicine","volume":"10","author":"Sun","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.ajps.2024.100943_bib0115","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.pharmthera.2017.02.020","article-title":"Exosomes: therapy delivery tools and biomarkers of diseases","volume":"174","author":"Barile","year":"2017","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.ajps.2024.100943_bib0116","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1080\/10717544.2020.1748758","article-title":"Prospects and challenges of extracellular vesicle-based drug delivery system: considering cell source","volume":"27","author":"Meng","year":"2020","journal-title":"Drug Deliv"},{"key":"10.1016\/j.ajps.2024.100943_bib0117","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.addr.2016.02.006","article-title":"Extracellular vesicles for drug delivery","volume":"106","author":"Vader","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.ajps.2024.100943_bib0118","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2018.1435138","article-title":"Immunoaffinity-based isolation of melanoma cell-derived exosomes from plasma of patients with melanoma","volume":"7","author":"Sharma","year":"2018","journal-title":"J Extracell Vesicles"},{"key":"10.1016\/j.ajps.2024.100943_bib0119","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jim.2011.06.024","article-title":"A filtration-based protocol to isolate human plasma membrane-derived vesicles and exosomes from blood plasma","volume":"371","author":"Grant","year":"2011","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.ajps.2024.100943_bib0120","doi-asserted-by":"crossref","first-page":"6466","DOI":"10.3390\/ijms21186466","article-title":"A review of exosomal isolation methods: is size exclusion chromatography the best option?","volume":"21","author":"Sidhom","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajps.2024.100943_bib0121","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202101562","article-title":"Cell membrane vesicles with enriched cxcr4 display enhances their targeted delivery as drug carriers to inflammatory sites","volume":"8","author":"Wang","year":"2021","journal-title":"Adv Sci"},{"key":"10.1016\/j.ajps.2024.100943_bib0122","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/s41392-021-00830-x","article-title":"Current hydrogel advances in physicochemical and biological response-driven biomedical application diversity","volume":"6","author":"Cao","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.ajps.2024.100943_bib0123","doi-asserted-by":"crossref","first-page":"eaaf3627","DOI":"10.1126\/science.aaf3627","article-title":"Advances in engineering hydrogels","volume":"356","author":"Zhang","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.ajps.2024.100943_bib0124","doi-asserted-by":"crossref","first-page":"16071","DOI":"10.1038\/natrevmats.2016.71","article-title":"Designing hydrogels for controlled drug delivery","volume":"1","author":"Li","year":"2016","journal-title":"Nat Rev Mater"},{"key":"10.1016\/j.ajps.2024.100943_bib0125","article-title":"pH\/ROS dual-sensitive and chondroitin sulfate wrapped poly (\u03b2-amino ester)-SA-PAPE copolymer nanoparticles for macrophage-targeted oral therapy for ulcerative colitis","volume":"39","author":"Xu","year":"2022","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ajps.2024.100943_bib0126","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1021\/acs.jafc.2c07777","article-title":"Mucoadhesive hydrogel with anti-gastric acid and sustained-release functions for amelioration of dss-induced ulcerative colitis","volume":"71","author":"Huang","year":"2023","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.ajps.2024.100943_bib0127","doi-asserted-by":"crossref","first-page":"eaam6431","DOI":"10.1126\/scirobotics.aam6431","article-title":"Micro\/nanorobots for biomedicine: delivery, surgery, sensing, and detoxification","volume":"2","author":"Li","year":"2017","journal-title":"Sci Robot"},{"key":"10.1016\/j.ajps.2024.100943_bib0128","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121551","article-title":"Micro\/nanorobots for precise drug delivery via targeted transport and triggered release: a review","volume":"616","author":"Xu","year":"2022","journal-title":"Int J Pharm"},{"key":"10.1016\/j.ajps.2024.100943_bib0129","doi-asserted-by":"crossref","first-page":"eadc8978","DOI":"10.1126\/sciadv.adc8978","article-title":"Twin-bioengine self-adaptive micro\/nanorobots using enzyme actuation and macrophage relay for gastrointestinal inflammation therapy","volume":"9","author":"Zhang","year":"2023","journal-title":"Sci Adv"},{"key":"10.1016\/j.ajps.2024.100943_bib0130","article-title":"Intestinal stem cells and immune cell relationships: potential therapeutic targets for inflammatory bowel diseases","volume":"11","author":"Hou","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajps.2024.100943_bib0131","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.actbio.2021.05.010","article-title":"Biomaterials for intestinal organoid technology and personalized disease modeling","volume":"132","author":"Hirota","year":"2021","journal-title":"Acta Biomater"},{"key":"10.1016\/j.ajps.2024.100943_bib0132","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1002\/bjs.11686","article-title":"Regenerative medicine, organ bioengineering and transplantation","volume":"107","author":"Edgar","year":"2020","journal-title":"Br J Surg"},{"key":"10.1016\/j.ajps.2024.100943_bib0133","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s41596-021-00658-3","article-title":"Transplantation of intestinal organoids into a mouse model of colitis","volume":"17","author":"Watanabe","year":"2022","journal-title":"Nat Protoc"},{"key":"10.1016\/j.ajps.2024.100943_bib0134","doi-asserted-by":"crossref","first-page":"47","DOI":"10.4103\/jphi.JPHI_32_17","article-title":"Application of three-dimensional printing for colon targeted drug delivery systems","volume":"7","author":"Charbe","year":"2017","journal-title":"Int J Pharm Investig"},{"key":"10.1016\/j.ajps.2024.100943_bib0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119428","article-title":"Stereolithography (SLA) 3D printing of ascorbic acid loaded hydrogels: a controlled release study","volume":"584","author":"Karakurt","year":"2020","journal-title":"Int J Pharm"},{"key":"10.1016\/j.ajps.2024.100943_bib0136","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.05.020","article-title":"Challenges of fused deposition modeling 3D printing in pharmaceutical applications: where are we now?","volume":"175","author":"Parulski","year":"2021","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.ajps.2024.100943_bib0137","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123639","article-title":"3D-printed prednisolone phosphate suppositories with tunable dose and rapid release for the treatment of inflammatory bowel disease","volume":"649","author":"Kocabas","year":"2024","journal-title":"Int J Pharm"},{"key":"10.1016\/j.ajps.2024.100943_bib0138","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120360","article-title":"3D printing of four-in-one oral polypill with multiple release profiles for personalized delivery of caffeine and vitamin B analogues","volume":"598","author":"Goh","year":"2021","journal-title":"Int J Pharm"},{"key":"10.1016\/j.ajps.2024.100943_bib0139","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.122680","article-title":"Form & formulation approaches for COntRollable release in 3D printed Colonic Targeting (CORR3CT) budesonide tablet","volume":"635","author":"Ou","year":"2023","journal-title":"Int J Pharm"},{"key":"10.1016\/j.ajps.2024.100943_bib0140","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1038\/s41418-018-0070-2","article-title":"Lactobacillus accelerates ISCs regeneration to protect the integrity of intestinal mucosa through activation of STAT3 signaling pathway induced by LPLs secretion of IL-22","volume":"25","author":"Hou","year":"2018","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.ajps.2024.100943_bib0141","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41588-020-00763-1","article-title":"Large-scale association analyses identify host factors influencing human gut microbiome composition","volume":"53","author":"Kurilshikov","year":"2021","journal-title":"Nat Genet"},{"key":"10.1016\/j.ajps.2024.100943_bib0142","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01087-19","article-title":"Bifidobacterium dentium fortifies the intestinal mucus layer via autophagy and calcium signaling pathways","volume":"10","author":"Engevik","year":"2019","journal-title":"MBio"},{"key":"10.1016\/j.ajps.2024.100943_bib0143","doi-asserted-by":"crossref","first-page":"16731","DOI":"10.1073\/pnas.0804812105","article-title":"Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients","volume":"105","author":"Sokol","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ajps.2024.100943_bib0144","article-title":"Prodrug integrated envelope on probiotics to enhance target therapy for ulcerative colitis","volume":"10","author":"Zhang","year":"2023","journal-title":"Adv Sci"},{"key":"10.1016\/j.ajps.2024.100943_bib0145","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/apt.14689","article-title":"Review article: short chain fatty acids as potential therapeutic agents in human gastrointestinal and inflammatory disorders","volume":"48","author":"Gill","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ajps.2024.100943_bib0146","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3389\/fimmu.2019.00277","article-title":"Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases","volume":"10","author":"Parada Venegas","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajps.2024.100943_bib0147","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/B978-0-12-800100-4.00003-9","article-title":"The role of short-chain fatty acids in health and disease","volume":"121","author":"Tan","year":"2014","journal-title":"Adv Immunol"},{"issue":"6145","key":"10.1016\/j.ajps.2024.100943_bib0148","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1126\/science.1241165","article-title":"The microbial metabolites, short chain fatty acids, regulate colonic Treg cell homeostasis","volume":"341","author":"Smith","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.ajps.2024.100943_bib0149","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/advances\/nmx009","article-title":"Butyrate: a double-edged sword for health?","volume":"9","author":"Liu","year":"2018","journal-title":"Adv Nutr"},{"key":"10.1016\/j.ajps.2024.100943_bib0150","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41551-022-00972-5","article-title":"Treatment of peanut allergy and colitis in mice via the intestinal release of butyrate from polymeric micelles","volume":"7","author":"Wang","year":"2023","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.ajps.2024.100943_bib0151","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1600-065X.2010.00970.x","article-title":"Immunology of gut mucosal vaccines","volume":"239","author":"Pasetti","year":"2011","journal-title":"Immunol Rev"},{"key":"10.1016\/j.ajps.2024.100943_bib0152","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/vaccines9010001","article-title":"Advances in oral subunit vaccine design","volume":"9","author":"Van der Weken","year":"2020","journal-title":"Vaccines"},{"key":"10.1016\/j.ajps.2024.100943_bib0153","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.addr.2011.07.003","article-title":"Gut-associated lymphoid tissues for the development of oral vaccines","volume":"64","author":"Kunisawa","year":"2012","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.ajps.2024.100943_bib0154","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/femsre\/fux048","article-title":"The role of toxins in Clostridium difficile infection","volume":"41","author":"Chandrasekaran","year":"2017","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.ajps.2024.100943_bib0155","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.3390\/pharmaceutics14051086","article-title":"Towards development of a non-toxigenic clostridioides difficile oral spore vaccine against toxigenic C. difficile","volume":"14","author":"Hughes","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ajps.2024.100943_bib0156","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.103017","article-title":"The influence of cytokines on the complex pathology of ulcerative colitis","volume":"21","author":"Nakase","year":"2022","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.ajps.2024.100943_bib0157","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103331","article-title":"Cytokines and intestinal epithelial permeability: a systematic review","volume":"22","author":"Meyer","year":"2023","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.ajps.2024.100943_bib0158","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1021\/acs.biomac.3c00146","article-title":"Orally administrated olsalazine-loaded multilayer pectin\/chitosan\/alginate composite microspheres for ulcerative colitis treatment","volume":"24","author":"Li","year":"2023","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ajps.2024.100943_bib0159","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.ebiom.2018.08.035","article-title":"Boosting mTOR-dependent autophagy via upstream TLR4-MyD88-MAPK signalling and downstream NF-\u03baB pathway quenches intestinal inflammation and oxidative stress injury","volume":"35","author":"Zhou","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ajps.2024.100943_bib0160","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1136\/gutjnl-2012-304241","article-title":"Claudin-1 regulates intestinal epithelial homeostasis through the modulation of Notch-signalling","volume":"63","author":"Pope","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.ajps.2024.100943_bib0161","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.gastro.2005.06.004","article-title":"Epidermal growth factor partially restores colonic ion transport responses in mouse models of chronic colitis","volume":"129","author":"McCole","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajps.2024.100943_bib0162","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.devcel.2020.07.009","article-title":"Intestinal regeneration: regulation by the microenvironment","volume":"54","author":"Hageman","year":"2020","journal-title":"Dev Cell"},{"key":"10.1016\/j.ajps.2024.100943_bib0163","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/nature16460","article-title":"Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration","volume":"528","author":"Lindemans","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ajps.2024.100943_bib0164","doi-asserted-by":"crossref","first-page":"37296","DOI":"10.1074\/jbc.M112.375881","article-title":"Toll-like receptor 4 is expressed on intestinal stem cells and regulates their proliferation and apoptosis via the p53 up-regulated modulator of apoptosis","volume":"287","author":"Neal","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajps.2024.100943_bib0165","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1053\/j.gastro.2014.02.009","article-title":"The microbiome in inflammatory bowel disease: current status and the future ahead","volume":"146","author":"Kostic","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajps.2024.100943_bib0166","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.109847","article-title":"Puerarin inhibits inflammation and oxidative stress in dextran sulfate sodium-induced colitis mice model","volume":"124","author":"Jeon","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.ajps.2024.100943_bib0167","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.molmed.2020.06.006","article-title":"Oxidative stress and redox-modulating therapeutics in inflammatory bowel disease","volume":"26","author":"Bourgonje","year":"2020","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.ajps.2024.100943_bib0168","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40035-023-00350-4","article-title":"Redox dysregulation as a driver for DNA damage and its relationship to neurodegenerative diseases","volume":"12","author":"Shadfar","year":"2023","journal-title":"Transl Neurodegener"},{"key":"10.1016\/j.ajps.2024.100943_bib0169","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/nutrit\/nuab015","article-title":"The complexities of approaching nutrition in inflammatory bowel disease: current recommendations and future directions","volume":"80","author":"Russell","year":"2022","journal-title":"Nutr Rev"},{"key":"10.1016\/j.ajps.2024.100943_bib0170","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jconrel.2023.05.007","article-title":"Wielding the double-edged sword: redox drug delivery systems for inflammatory bowel disease","volume":"358","author":"Chen","year":"2023","journal-title":"J Controll Release"},{"key":"10.1016\/j.ajps.2024.100943_bib0171","doi-asserted-by":"crossref","first-page":"eabp9882","DOI":"10.1126\/sciadv.abp9882","article-title":"Oral zero-valent-molybdenum nanodots for inflammatory bowel disease therapy","volume":"8","author":"Zhang","year":"2022","journal-title":"Sci Adv"},{"key":"10.1016\/j.ajps.2024.100943_bib0172","doi-asserted-by":"crossref","first-page":"15026","DOI":"10.1021\/acsnano.2c06151","article-title":"Ultrathin hafnium disulfide atomic crystals with ros-scavenging and colon-targeting capabilities for inflammatory bowel disease treatment","volume":"16","author":"Li","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.ajps.2024.100943_bib0173","doi-asserted-by":"crossref","first-page":"12096","DOI":"10.1007\/s11356-020-07740-5","article-title":"Toxicity of multi-wall carbon nanotubes inhalation on the brain of rats","volume":"27","author":"Samiei","year":"2020","journal-title":"Environ Sci Pollut Res Int"},{"key":"10.1016\/j.ajps.2024.100943_bib0174","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/10408440600570233","article-title":"A review of carbon nanotube toxicity and assessment of potential occupational and environmental health risks","volume":"36","author":"Lam","year":"2006","journal-title":"Crit Rev Toxicol"},{"key":"10.1016\/j.ajps.2024.100943_bib0175","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.taap.2019.05.001","article-title":"Pulmonary toxicity of two different multi-walled carbon nanotubes in rat: comparison between intratracheal instillation and inhalation exposure","volume":"375","author":"Gat\u00e9","year":"2019","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.ajps.2024.100943_bib0176","doi-asserted-by":"crossref","first-page":"e1498","DOI":"10.1002\/wnan.1498","article-title":"Mechanisms of carbon nanotube-induced pulmonary fibrosis: a physicochemical characteristic perspective","volume":"10","author":"Duke","year":"2018","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"10.1016\/j.ajps.2024.100943_bib0177","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.eng.2023.01.014","article-title":"Artificial intelligence in pharmaceutical sciences","volume":"27","author":"Lu","year":"2023","journal-title":"Engineering"},{"key":"10.1016\/j.ajps.2024.100943_bib0178","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/s41573-023-00774-7","article-title":"Artificial intelligence for natural product drug discovery","volume":"22","author":"Mullowney","year":"2023","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.ajps.2024.100943_bib0179","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113922","article-title":"Artificial intelligence and machine learning assisted drug delivery for effective treatment of infectious diseases","volume":"178","author":"He","year":"2021","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.ajps.2024.100943_bib0180","doi-asserted-by":"crossref","first-page":"e1568","DOI":"10.1002\/wcms.1568","article-title":"Machine learning in drug design: use of artificial intelligence to explore the chemical structure\u2013biological activity relationship","volume":"12","author":"Staszak","year":"2022","journal-title":"WIREs Comput Mol Sci"},{"key":"10.1016\/j.ajps.2024.100943_bib0181","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-023-38056-w","article-title":"Machine learning-driven multifunctional peptide engineering for sustained ocular drug delivery","volume":"14","author":"Hsueh","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajps.2024.100943_bib0182","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jconrel.2023.07.040","article-title":"An artificial intelligence-assisted physiologically-based pharmacokinetic model to predict nanoparticle delivery to tumors in mice","volume":"361","year":"2023","journal-title":"J Controll Release"},{"key":"10.1016\/j.ajps.2024.100943_bib0183","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.3390\/pharmaceutics15041260","article-title":"Artificial intelligence in drug metabolism and excretion prediction: recent advances, challenges, and future perspectives","volume":"15","author":"Tran","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ajps.2024.100943_bib0184","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2024.148779","article-title":"Computational insights into carbon dots: evolution of structural models and structure\u2013activity relationships","volume":"481","author":"Zhao","year":"2024","journal-title":"Chem Eng J"},{"key":"10.1016\/j.ajps.2024.100943_bib0185","doi-asserted-by":"crossref","first-page":"8575","DOI":"10.1021\/acs.chemrev.3c00070","article-title":"Converting nanotoxicity data to information using artificial intelligence and simulation","volume":"123","author":"Yan","year":"2023","journal-title":"Chem Rev"},{"key":"10.1016\/j.ajps.2024.100943_bib0186","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2023.108025","article-title":"Machine learning-driven QSAR models for predicting the mixture toxicity of nanoparticles","volume":"177","author":"Zhang","year":"2023","journal-title":"Environ Int"},{"key":"10.1016\/j.ajps.2024.100943_bib0187","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.addr.2019.05.001","article-title":"The significance of artificial intelligence in drug delivery system design","volume":"151-152","year":"2019","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.ajps.2024.100943_bib0188","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-024-01745-z","article-title":"Nanotechnology's frontier in combatting infectious and inflammatory diseases: prevention and treatment","volume":"9","author":"Huang","year":"2024","journal-title":"Sig Transduct Target Ther"},{"key":"10.1016\/j.ajps.2024.100943_bib0189","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41586-021-03275-y","article-title":"BNT162b vaccines protect rhesus macaques from SARS-CoV-2","volume":"592","author":"Vogel","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ajps.2024.100943_bib0190","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mrna-1273 sars-cov-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajps.2024.100943_bib0191","doi-asserted-by":"crossref","first-page":"eadg1036","DOI":"10.1126\/sciadv.adg1036","article-title":"A single-dose F1-based mRNA-LNP vaccine provides protection against the lethal plague bacterium","volume":"9","author":"Kon","year":"2023","journal-title":"Sci Adv"},{"key":"10.1016\/j.ajps.2024.100943_bib0192","doi-asserted-by":"crossref","first-page":"7405","DOI":"10.1038\/s41467-022-35074-y","article-title":"A self-powered ingestible wireless biosensing system for real-time in situ monitoring of gastrointestinal tract metabolites","volume":"13","author":"De la","year":"2022","journal-title":"Nat Commun"}],"container-title":["Asian Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1818087624000606?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1818087624000606?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T16:15:17Z","timestamp":1725552917000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1818087624000606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":192,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S1818087624000606"],"URL":"https:\/\/doi.org\/10.1016\/j.ajps.2024.100943","relation":{},"ISSN":["1818-0876"],"issn-type":[{"value":"1818-0876","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design strategies, advances and future perspectives of colon-targeted delivery systems for the treatment of inflammatory bowel disease","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajps.2024.100943","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Shenyang Pharmaceutical University. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100943"}}